Dr. Cheryl Healton is responsible for building the School of Global Public Health’s academic, service, and research programs, which focus on domestic and international health with an emphasis on prevention, systems intervention, and innovation in public health practice.
Previously, as the founding President and CEO of Legacy – a leading organization dedicated to tobacco control – Dr. Healton worked to further the foundation’s mission: to build a world where young people reject tobacco and anyone can quit. During her time with Legacy, she guided the national youth tobacco prevention counter-marketing campaign, truth®, which has been credited with reducing youth smoking prevalence to near record lows. Legacy launched a national smoking cessation campaign, public education campaigns, technical assistance, and a broad program of grant making. Additionally, Legacy established the Steven A. Schroeder Institute for Tobacco Studies.
Prior to Legacy, Dr. Healton held numerous roles at Columbia University, worked to expand the scope of public health programs, and undertook innovative educational initiatives to advance public health practice.
Through her research, she has published over 100 peer-reviewed papers and special reports on public health related topics including HIV/AIDS, public health education, health policy, substance abuse, and tobacco. She was the founding chair of the Public Health Practice Council of the Association of Schools of Public Health and is an active member of the public health community, serving on the National Board of Public Health Examiners, the Betty Ford Institute, and Lung Cancer Alliance. She also serves on the Board of Directors at the Association of Schools and Programs of Public Health, and the Board of Directors at HealthRight International.
Dr. Healton has given presentations around the world and is a frequent commentator on national and local broadcasts and print news coverage of tobacco control issues.